open access

Vol 5, No 4 (2008)
Research paper
Published online: 2008-12-16
Get Citation

Study program on opinions of schizophrenic patients treated with antipsychotics

Marek Krzystanek, Krystyna Bednarska-Półtorak, Ewa Krzystanek, Irena Krupka-Matuszczyk
Psychiatria 2008;5(4):117-123.

open access

Vol 5, No 4 (2008)
Prace oryginalne - nadesłane
Published online: 2008-12-16

Abstract


Introduction. Noncompliance is one of most frequent reasons of discontinuation of therapy and lack of effectiveness of psychiatric disorders treatment. Many factors may influence on noncompliance, e.g. type of disease, phenomenon of stigmatization with mental disease and quality of patient-doctor relation. The study aimed to explore opinions of patients treated with new generation antipsychotics. Material and methods. One thousand four hundred out-patients treated with one of second generation antipsychotics were studied.
Results. Patients considered anxiety, tension, delusions and hallucinations the most important symptoms to be released from. Most attracting neuroleptic side effects were drowsiness, sexual dysfunctions, obesity and extrapyramidal symptoms. More than 80% of patients treated with modern neuroleptics wanted to treat schizophrenia; 82% patients thought that the treatment with atipsychotics produces side effects. In opinion of 81% of subjects level of family and society functioning was improved by intake of antipsychotics; 74% patients worried about side effects of antipsychotics and 70% did not tell nobody they take antipsychotic drug; 77% of patients claimed that schizophrenia treatment is effective. No more than 40% of patients felt bad or unnatural using antipsychotic drug.
Conclusions. Patients treated with second generation antipsychotics may be characterized with good compliance. In opinion of patients most important in the treatment of schizophrenia are productive and affective symptoms. Most interfering side effects of neuroleptics are sedation, sexual dysfunctions, obesity and extrapyramidal symptoms. Stigmatization phenomenon is abundant in the examinated group of people with schizophrenia.

Abstract


Introduction. Noncompliance is one of most frequent reasons of discontinuation of therapy and lack of effectiveness of psychiatric disorders treatment. Many factors may influence on noncompliance, e.g. type of disease, phenomenon of stigmatization with mental disease and quality of patient-doctor relation. The study aimed to explore opinions of patients treated with new generation antipsychotics. Material and methods. One thousand four hundred out-patients treated with one of second generation antipsychotics were studied.
Results. Patients considered anxiety, tension, delusions and hallucinations the most important symptoms to be released from. Most attracting neuroleptic side effects were drowsiness, sexual dysfunctions, obesity and extrapyramidal symptoms. More than 80% of patients treated with modern neuroleptics wanted to treat schizophrenia; 82% patients thought that the treatment with atipsychotics produces side effects. In opinion of 81% of subjects level of family and society functioning was improved by intake of antipsychotics; 74% patients worried about side effects of antipsychotics and 70% did not tell nobody they take antipsychotic drug; 77% of patients claimed that schizophrenia treatment is effective. No more than 40% of patients felt bad or unnatural using antipsychotic drug.
Conclusions. Patients treated with second generation antipsychotics may be characterized with good compliance. In opinion of patients most important in the treatment of schizophrenia are productive and affective symptoms. Most interfering side effects of neuroleptics are sedation, sexual dysfunctions, obesity and extrapyramidal symptoms. Stigmatization phenomenon is abundant in the examinated group of people with schizophrenia.
Get Citation

Keywords

schizophrenia; compliance; productive symptoms; affective symptoms; atypical neuroleptics; side effects; stigmatization

About this article
Title

Study program on opinions of schizophrenic patients treated with antipsychotics

Journal

Psychiatria (Psychiatry)

Issue

Vol 5, No 4 (2008)

Article type

Research paper

Pages

117-123

Published online

2008-12-16

Bibliographic record

Psychiatria 2008;5(4):117-123.

Keywords

schizophrenia
compliance
productive symptoms
affective symptoms
atypical neuroleptics
side effects
stigmatization

Authors

Marek Krzystanek
Krystyna Bednarska-Półtorak
Ewa Krzystanek
Irena Krupka-Matuszczyk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl